Ethan Shen Ph.D., CEO at YD Bio Ltd (YDES), bought 12,700 shares at $3.85 ($49K) on 2026-09-14, disclosed to the SEC on 2026-09-16.
CEO Ethan Shen Ph.D. purchased $48,895 worth of YD Bio shares at $3.85, signaling confidence in the stock's recent recovery. The buy comes as the stock has surged 20.29% over the last 30 days, recovering from a 23.48% discount to its 52-week high.
YD Bio is up 2.31% over the last 5 days and 20.29% over the last 30 days, currently trading at $3.765. The stock is down 23.48% from its 52-week high of $4.92 but up 79.29% from its 52-week low of $2.10.
Insider purchase by CEO Ethan Shen Ph.D. on September 14, 2026, signaling confidence in the stock's recovery.
The stock is currently trading at a premium of 79.29% above its 52-week low of $2.10, which could limit further upside if the recent momentum fades.
Nothing distinguishes this filing.
| Filing → |